{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T02:09:05Z","timestamp":1786759745218,"version":"build-2736575974"},"reference-count":70,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Preventive Medicine"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.ypmed.2013.01.020","type":"journal-article","created":{"date-parts":[[2013,2,9]],"date-time":"2013-02-09T00:00:52Z","timestamp":1360368052000},"page":"426-433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Evolution of cervical cancer screening and prevention in United States and Canada: Implications for public health practitioners and clinicians"],"prefix":"10.1016","volume":"57","author":[{"given":"M.","family":"Saraiya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Steben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Markowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ypmed.2013.01.020_bb0005","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0029-7844(03)00745-2","article-title":"ACOG practice bulletin: clinical management guidelines for obstetrician-gynecologists. Number 45, August 2003. Cervical cytology screening","volume":"102","author":"ACOG","year":"2003","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ypmed.2013.01.020_bb0015","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/cncy.20203","article-title":"Cervical screening in England: the past, present, and future","volume":"120","author":"Albrow","year":"2012","journal-title":"Cancer Cytopathol."},{"key":"10.1016\/j.ypmed.2013.01.020_bb0020","first-page":"1409","volume":"No. 109","author":"American College of Obstetricians and Gynecologists","year":"2009"},{"key":"10.1016\/j.ypmed.2013.01.020_bb0025","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1748-5908-6-112","article-title":"Effective interventions to facilitate the uptake of breast, cervical and colorectal cancer screening: an implementation guideline","volume":"6","author":"Brouwers","year":"2011","journal-title":"Implement. Sci."},{"key":"10.1016\/j.ypmed.2013.01.020_bb0030","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/1748-5908-6-111","article-title":"What implementation interventions increase cancer screening rates? A systematic review","volume":"6","author":"Brouwers","year":"2011","journal-title":"Implement. Sci."},{"key":"10.1016\/j.ypmed.2013.01.020_bb0035","series-title":"Canadian cancer statistics 2012, Ontario, Canada","author":"Canadian Cancer Society's Steering Committee on Cancer Statistics","year":"2012"},{"key":"10.1016\/j.ypmed.2013.01.020_bb0040","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1503\/cmaj.121505","article-title":"Recommendations on screening for cervical cancer","volume":"185","author":"Canadian Task Force on Preventive Health Care","year":"2013","journal-title":"CMAJ"},{"key":"10.1016\/j.ypmed.2013.01.020_bb0050","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1002\/cncr.23762","article-title":"Predicting the effect of successful human papillomavirus vaccination on existing cervical cancer prevention programs in the United States","volume":"113","author":"Castle","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.ypmed.2013.01.020_bb0060","first-page":"630","article-title":"FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP)","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.ypmed.2013.01.020_bb0065","first-page":"1705","article-title":"Recommendations on the use of quadrivalent human papillomavirus vaccine in males\u2014Advisory Committee on Immunization Practices (ACIP), 2011","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.ypmed.2013.01.020_bb0070","first-page":"619","article-title":"Ten great public health achievements\u2014United States, 2001\u20132010","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.ypmed.2013.01.020_bb0075","first-page":"41","article-title":"Cancer screening \u2014 United States, 2010","volume":"61","author":"Centers for Disease Control and Prevention","year":"2012","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.ypmed.2013.01.020_bb0080","first-page":"671","article-title":"National and state vaccination coverage among adolescents aged 13\u201317years \u2014 United States, 2011","volume":"61","author":"Centers for Disease Control and Prevention","year":"2012","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.ypmed.2013.01.020_bb0085","first-page":"626","article-title":"FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP)","volume":"59","author":"Centers for Disease Control Prevention","year":"2010","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.ypmed.2013.01.020_bb0055","unstructured":"Centers for Disease Control and Prevention, Vaccine For Children. http:\/\/www.cdc.gov\/vaccines\/programs\/vfc\/about\/index.html."},{"key":"10.1016\/j.ypmed.2013.01.020_bb0090","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1258\/jms.2012.012011","article-title":"Dry self-sampling versus provider-sampling of cervicovaginal specimens for human papillomavirus detection in the Inuit population of Nunavik, Quebec","volume":"19","author":"Cerigo","year":"2012","journal-title":"J. Med. Screen."},{"key":"10.1016\/j.ypmed.2013.01.020_bb0095","doi-asserted-by":"crossref","first-page":"8443","DOI":"10.1016\/j.vaccine.2011.07.096","article-title":"The cost-effectiveness of male HPV vaccination in the United States","volume":"29","author":"Chesson","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.ypmed.2013.01.020_bb0100","doi-asserted-by":"crossref","first-page":"6016","DOI":"10.1016\/j.vaccine.2012.07.056","article-title":"Estimates of the annual direct medical costs of the prevention and treatment of disease associated with human papillomavirus in the United States","volume":"30","author":"Chesson","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.ypmed.2013.01.020_bb0105","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.amepre.2012.04.008","article-title":"Updated recommendations for client- and provider-oriented interventions to increase breast, cervical, and colorectal cancer screening","volume":"43","author":"Community Preventive Services Task Force","year":"2012","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.ypmed.2013.01.020_bb0110","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1542\/peds.2011-0950","article-title":"Human papillomavirus vaccination series initiation and completion, 2008\u20132009","volume":"128","author":"Dorell","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.ypmed.2013.01.020_bb0115","series-title":"Excess Cervical Cancer Mortality: a Marker for Low Access to Health Care in Poor Communities","author":"Freeman","year":"2005"},{"key":"10.1016\/j.ypmed.2013.01.020_bb0120","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1478-7954-5-11","article-title":"Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccination","volume":"5","author":"Goldhaber-Fiebert","year":"2007","journal-title":"Popul. Health Metrics"},{"key":"10.1016\/j.ypmed.2013.01.020_bb0010","author":"GSK"},{"key":"10.1016\/j.ypmed.2013.01.020_bb0125","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1468-0009.2011.00652.x","article-title":"Cervical cancer screening in the United States and the Netherlands: a tale of two countries","volume":"90","author":"Habbema","year":"2012","journal-title":"Milbank Q."},{"key":"10.1016\/j.ypmed.2013.01.020_bb0130","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1467-9566.2011.01411.x","article-title":"A molecular monopoly? HPV testing, the Pap smear and the molecularisation of cervical cancer screening in the USA","volume":"34","author":"Hogarth","year":"2012","journal-title":"Sociol. Health Illn."},{"key":"10.1016\/j.ypmed.2013.01.020_bb0135","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1158\/1055-9965.EPI-10-1183","article-title":"U.S. geographic distribution of prevaccine era cervical cancer screening, incidence, stage, and mortality","volume":"20","author":"Horner","year":"2011","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.ypmed.2013.01.020_bb0140","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/S1701-2163(16)32584-1","article-title":"Summary recommendations: Canadian consensus guidelines on human papillomavirus","volume":"29","author":"HPV Consensus Guidelines Committee","year":"2007","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"10.1016\/j.ypmed.2013.01.020_bb0145","series-title":"Clinical Preventive Services for Women: Closing the Gaps, Washington, DC","author":"Institute of Medicine","year":"2011"},{"key":"10.1016\/j.ypmed.2013.01.020_bb0150","first-page":"483","article-title":"Periodic Health Examination, 1995 update: 1. Screening for human papillomavirus infection in asymptomatic women","volume":"152","author":"Johnson","year":"1995","journal-title":"Can. Med. Assoc. J."},{"key":"10.1016\/j.ypmed.2013.01.020_bb0155","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/AOG.0b013e3182210034","article-title":"Low-risk human papillomavirus testing and other nonrecommended human papillomavirus testing practices among U.S. health care providers","volume":"118","author":"Lee","year":"2011","journal-title":"Obstet. Gynecol."},{"issue":"9","key":"10.1016\/j.ypmed.2013.01.020_bb0160","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1002\/ijc.27850","article-title":"The HPV Test has Similar Sensitivity but more Overdiagnosis than the Pap test \u2014 a Randomised Health Services Study on Cervical Cancer Screening in Finland","volume":"132","author":"Malila","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ypmed.2013.01.020_bb0170","first-page":"1","article-title":"Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Markowitz","year":"2007","journal-title":"MMWR Recomm. Rep."},{"key":"10.1016\/j.ypmed.2013.01.020_bb0175","first-page":"2","article-title":"Changing the Primary Screening Tool of the Netherlands Program: Why and How? HPV Today","author":"Meijer","year":"2011"},{"key":"10.1016\/j.ypmed.2013.01.020_bb0180","series-title":"Gardasil Product Monograph","author":"Merck Canada Inc.","year":"2012"},{"issue":"12","key":"10.1016\/j.ypmed.2013.01.020_bb0185","doi-asserted-by":"crossref","first-page":"880","DOI":"10.7326\/0003-4819-156-12-201206190-00424","article-title":"Screening for cervical cancer: U.S. preventive services task force recommendation statement. Ann. Intern","volume":"156","author":"Moyer","year":"2012","journal-title":"Med"},{"key":"10.1016\/j.ypmed.2013.01.020_bb0190","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1701-2163(16)35242-2","article-title":"Cervical screening: a guideline for clinical practice in Ontario","volume":"34","author":"Murphy","year":"2012","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"10.1016\/j.ypmed.2013.01.020_bb0195","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1701-2163(16)35241-0","article-title":"HPV testing in primary cervical screening: a systematic review and meta-analysis","volume":"34","author":"Murphy","year":"2012","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"10.1016\/j.ypmed.2013.01.020_bb0210","first-page":"1","article-title":"Statement on human papillomavirus vaccine. An Advisory Committee Statement (ACS)","volume":"33","author":"National Advisory Committee on Immunization (NACI)","year":"2007","journal-title":"Can. Commun. Dis. Rep."},{"key":"10.1016\/j.ypmed.2013.01.020_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14745\/ccdr.v38i00a01","article-title":"Update on human papillomavirus (HPV) vaccines. An Advisory Committee Statement (ACS)","volume":"38","author":"National Advisory Committee on Immunization (NACI)","year":"2012","journal-title":"Can. Commun. Dis. Rep."},{"key":"10.1016\/j.ypmed.2013.01.020_bb0215","first-page":"95","article-title":"Human papillomavirus vaccine program in BC: a good start with room for improvement","volume":"52","author":"Naus","year":"2010","journal-title":"BCMJ"},{"key":"10.1016\/j.ypmed.2013.01.020_bb0220","unstructured":"Niemenen, P., 2012. Optimizing Cervical Cancer Screening in Finland, HPV Today, Sept 2012 ed. BYPASS EDICIONES, Belgium, pp. 2."},{"key":"10.1016\/j.ypmed.2013.01.020_bb0225","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/00004347-199304000-00018","article-title":"Natural history of cervical intraepithelial neoplasia: a critical review","volume":"12","author":"Ostor","year":"1993","journal-title":"Int. J. Gynecol. Pathol."},{"issue":"17","key":"10.1016\/j.ypmed.2013.01.020_bb0230","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJMoa1010971","article-title":"HPV vaccine against anal HPV infection and anal intraepithelial neoplasia","volume":"365","author":"Palefsky","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"2 Pt 1","key":"10.1016\/j.ypmed.2013.01.020_bb0235","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/AOG.0b013e3182253c33","article-title":"Trends of human papillomavirus testing in cervical cancer screening at a large academic cytology laboratory","volume":"118","author":"Phelan","year":"2011","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ypmed.2013.01.020_bb0240","first-page":"s15","article-title":"The role of HPV testing. In: Canadian consensus guidelines on human papillomavirus","volume":"29","author":"Provencher DM","year":"2007","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"10.1016\/j.ypmed.2013.01.020_bb0245","series-title":"Cervical Cancer Facts and Figures","author":"Public Health Agency of Canada","year":"2012"},{"key":"10.1016\/j.ypmed.2013.01.020_bb0250","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/jnci\/djn044","article-title":"Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections","volume":"100","author":"Rodriguez","year":"2008","journal-title":"J. Natl. Cancer Inst."},{"issue":"447","key":"10.1016\/j.ypmed.2013.01.020_bb0255","first-page":"e441","article-title":"Human papillomavirus and Papanicolaou tests screening interval recommendations in the United States","volume":"205","author":"Roland","year":"2011","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ypmed.2013.01.020_bb0260","first-page":"e1","article-title":"Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors","volume":"36","author":"Ronco","year":"2012","journal-title":"Epidemiol. Prev."},{"key":"10.1016\/j.ypmed.2013.01.020_bb0265","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.amepre.2012.04.009","volume":"43","author":"Sabatino","year":"2012","journal-title":"Am. J. Prev. Med."},{"issue":"11","key":"10.1016\/j.ypmed.2013.01.020_bb0275","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1001\/archinternmed.2010.134","article-title":"Human papillomavirus co-testing: what screening intervals are physicians recommending","volume":"170","author":"Saraiya","year":"2010","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ypmed.2013.01.020_bb0280","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/LGT.0b013e31824ca9d5","article-title":"American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer","volume":"16","author":"Saslow","year":"2012","journal-title":"J. Low. Genit. Tract Dis."},{"key":"10.1016\/j.ypmed.2013.01.020_bb0285","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1002\/cncr.25065","article-title":"Cervical cancer prevention: new tools and old barriers","volume":"116","author":"Scarinci","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.ypmed.2013.01.020_bb0290","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/jnci\/djq562","article-title":"Human papillomavirus testing in the prevention of cervical cancer","volume":"103","author":"Schiffman","year":"2011","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ypmed.2013.01.020_bb0295","doi-asserted-by":"crossref","first-page":"45","DOI":"10.24095\/hpcdp.31.1.08","article-title":"Executive summary\u2014performance monitoring for cervical cancer screening programs in Canada","volume":"31","author":"Screening Performance Indicators Working Group, Cervical Cancer Prevention and Control Network","year":"2010","journal-title":"Chronic Dis. Can."},{"key":"10.1016\/j.ypmed.2013.01.020_bb0300","doi-asserted-by":"crossref","first-page":"45","DOI":"10.7326\/0003-4819-150-1-200901060-00009","article-title":"Immunization policy development in the United States: the role of the Advisory Committee on Immunization Practices","volume":"150","author":"Smith","year":"2009","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ypmed.2013.01.020_bb0305","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/jnci\/93.4.293","article-title":"Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial","volume":"93","author":"Solomon","year":"2001","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ypmed.2013.01.020_bb0310","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ypmed.2007.06.007","article-title":"Process of care failures in invasive cervical cancer: systematic review and meta-analysis","volume":"45","author":"Spence","year":"2007","journal-title":"Prev. Med."},{"key":"10.1016\/j.ypmed.2013.01.020_bb0315","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S1701-2163(16)32636-6","article-title":"Self-collected samples for testing of oncogenic human papillomavirus: a systematic review","volume":"29","author":"Stewart","year":"2007","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"10.1016\/j.ypmed.2013.01.020_bb0325","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1001\/archinternmed.2011.575","article-title":"The pelvic examination as a screening tool: practices of US physicians","volume":"171","author":"Stormo","year":"2011","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ypmed.2013.01.020_bb0320","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ypmed.2012.03.012","article-title":"Physician characteristics and beliefs associated with use of pelvic examinations in asymptomatic women","volume":"54","author":"Stormo","year":"2012","journal-title":"Prev. Med."},{"key":"10.1016\/j.ypmed.2013.01.020_bb0330","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S1701-2163(16)30423-6","article-title":"Report of the 2003 Pan-Canadian forum on cervical cancer prevention and control","volume":"26","author":"Stuart","year":"2004","journal-title":"Obstet. Gynaecol. Can."},{"key":"10.1016\/j.ypmed.2013.01.020_bb0335","doi-asserted-by":"crossref","first-page":"e1437","DOI":"10.1542\/peds.2011-1714","article-title":"Effectiveness and net cost of reminder\/recall for adolescent immunizations","volume":"129","author":"Suh","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.ypmed.2013.01.020_bb0340","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1309\/AJCPPVX91HQMNYZZ","article-title":"Practice patterns in cervical cancer screening and human papillomavirus testing","volume":"138","author":"Tatsas","year":"2012","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.ypmed.2013.01.020_bb0345","series-title":"United States Cancer Statistics 1999\u20132008 Incidence and Mortality Web-based Report","author":"U.S. Cancer Statistics Working Group","year":"2010"},{"key":"10.1016\/j.ypmed.2013.01.020_bb0350","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1057\/jphp.2012.8","article-title":"Relative risk of cervical cancer in indigenous women in Australia, Canada, New Zealand, and the United States: a systematic review and meta-analysis","volume":"33","author":"Vasilevska","year":"2012","journal-title":"J. Public Health Policy"},{"key":"10.1016\/j.ypmed.2013.01.020_bb0355","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1363\/3600604","article-title":"Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000","volume":"36","author":"Weinstock","year":"2004","journal-title":"Perspect. Sex. Reprod. Health"},{"key":"10.1016\/j.ypmed.2013.01.020_bb0360","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/jnci\/djn510","article-title":"Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States","volume":"101","author":"Wheeler","year":"2009","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ypmed.2013.01.020_bb0365","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1001\/jama.287.16.2120","article-title":"2001 Consensus guidelines for the management of women with cervical cytological abnormalities","volume":"287","author":"Wright","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ypmed.2013.01.020_bb0370","first-page":"569","article-title":"Human papilloma viruses and cancer","author":"zur Hausen","year":"1975","journal-title":"Bibl. Haematol."}],"container-title":["Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743513000339?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743513000339?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,5]],"date-time":"2024-05-05T19:12:49Z","timestamp":1714936369000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091743513000339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":70,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0091743513000339"],"URL":"https:\/\/doi.org\/10.1016\/j.ypmed.2013.01.020","relation":{},"ISSN":["0091-7435"],"issn-type":[{"value":"0091-7435","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evolution of cervical cancer screening and prevention in United States and Canada: Implications for public health practitioners and clinicians","name":"articletitle","label":"Article Title"},{"value":"Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ypmed.2013.01.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}